Description
+ Include: 16 videos: 3.32 GB
+ Target Audience: practicing radiologists, nuclear medicine physicians
+ Sample video: contact me for sample video
+ Information:
Educational Objectives
This course provides a clinical perspective of PET/CT imaging and the emerging use of Theranostic agents within Nuclear Medicine. A broad perspective on the economic, clinical, and academic aspects of the latest trends in PET/CT imaging and Nuclear Medicine therapy will be presented.
At the conclusion of this course, participants will be able to:
Describe new developments in the merger of diagnostic and therapeutic radioligands for PET/CT imaging and therapy with specific focus on DOTA, PSMA, and PRRT
Describe the logistis of bringing these new diagnostic and therapeutic technologies to clinical practice
Identify the key clinical indications for new emerging tracers for Neuroendocrine Tumor and Prostate cancer using somatostatin receptor and PSMA PET/CT imaging
Review and discuss the standard-of-care clinical application and advanced interpretation of FDG PET/CT
With the recent approval by CMS Medicare for DOTATATE (NETSPOT) PET/CT and the rapid international adoption of targeted Lu-177 based therapies for neuroendocrine and prostate cancers, it is clear that Nuclear Medicine and PET/CT are entering into a new era. New diagnostic and therapeutic agents with remarkable sensitivity and specificity are revolutionizing Nuclear Medicine and Oncology. This course will highlight the latest targeted imaging agents for neuroendocrine and prostate cancers (Ga-68 DOTATATE and Ga-68 PSMA PET/CT) as well as review important core concepts in PET/CT imaging and therapeutic Nuclear Medicine.
Target Audience
This course is intended for practicing radiologists, nuclear medicine physicians and radiologic nurses, physician assistants, technologists, residents, fellows and others who are interested in the clinical applications of PET and PET/CT.
Release date: 12/14/2023
+ Topics:
01 – Introduction to Theranostics.mp4
02 – Challenging and Instructive Abdomen and Pelvis.mp4
03 – Important of Patient Preparation for PET,CT.mp4
04 – PET,CT in Head and Neck Cancer.mp4
05 – Update on Radioiodine Treatment for Thyroid Cancer.mp4
06 – Nuclear Medicine and Benign Thyroid Disease.mp4
07 – Challenging and Interactive Chest PET,CT.mp4
08 – Neuroendocrine Tumor Imaging with DOTA PET,CT.mp4
09 – Update on Nuclear Medicine for Infection and Inflammation.mp4
10 – Lu-177 PSMA Therapy Lessons from the Vision Trial.mp4
11 – General Nuclear Medicine in 60 Minutes.mp4
12 – PET Imaging for the Differential Diagnosis of Dementia.mp4
13 – Dopamine Transporter Imaging of Parkinsonian Syndromes.mp4
14 – Somatostatin Radiotherapy – Our New Era of Nuclear Medicine.mp4
15 – Prostate Cancer PET Imaging.mp4
16 – Neurotheranostics – Next Frontier for Health Span.mp4
Reviews
There are no reviews yet.